219 related articles for article (PubMed ID: 36110516)
1. The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis.
Logan A; Belli A; Di Pietro V; Tavazzi B; Lazzarino G; Mangione R; Lazzarino G; Morano I; Qureshi O; Bruce L; Barnes NM; Nagy Z
Front Pharmacol; 2022; 13():983853. PubMed ID: 36110516
[No Abstract] [Full Text] [Related]
2. ILB
Lazzarino G; Di Pietro V; Rinaudo M; Nagy Z; Barnes NM; Bruce L; Signoretti S; Mangione R; Saab MW; Tavazzi B; Belli A; Lazzarino G; Amorini AM; Logan A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955592
[TBL] [Abstract][Full Text] [Related]
3. A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis.
Logan A; Nagy Z; Barnes NM; Belli A; Di Pietro V; Tavazzi B; Lazzarino G; Lazzarino G; Bruce L; Persson LI
PLoS One; 2022; 17(5):e0267183. PubMed ID: 35613082
[TBL] [Abstract][Full Text] [Related]
4. Low Molecular Weight Dextran Sulfate (ILB
Lazzarino G; Amorini AM; Barnes NM; Bruce L; Mordente A; Lazzarino G; Pietro VD; Tavazzi B; Belli A; Logan A
Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32927770
[TBL] [Abstract][Full Text] [Related]
5. ILB
Lazzarino G; Mangione R; Belli A; Di Pietro V; Nagy Z; Barnes NM; Bruce L; Ropero BM; Persson LI; Manca B; Saab MW; Amorini AM; Tavazzi B; Lazzarino G; Logan A
J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442438
[TBL] [Abstract][Full Text] [Related]
6. ILB
Hill LJ; Botfield HF; Begum G; Qureshi O; Vigneswara V; Masood I; Barnes NM; Bruce L; Logan A
NPJ Regen Med; 2021 Jan; 6(1):3. PubMed ID: 33414477
[TBL] [Abstract][Full Text] [Related]
7.
R M N; Joy A
J Biomol Struct Dyn; 2023 Oct; ():1-14. PubMed ID: 37850491
[TBL] [Abstract][Full Text] [Related]
8. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.
Kalmar B; Lu CH; Greensmith L
Pharmacol Ther; 2014 Jan; 141(1):40-54. PubMed ID: 23978556
[TBL] [Abstract][Full Text] [Related]
9. Glutamate, excitotoxicity and amyotrophic lateral sclerosis.
Shaw PJ; Ince PG
J Neurol; 1997 May; 244 Suppl 2():S3-14. PubMed ID: 9178165
[TBL] [Abstract][Full Text] [Related]
10. Expression of Notch and Wnt/β-catenin signaling pathway in acute phase severe brain injury rats and the effect of exogenous thyroxine on those pathways.
Wei C; Luo Y; Peng L; Huang Z; Pan Y
Eur J Trauma Emerg Surg; 2021 Dec; 47(6):2001-2015. PubMed ID: 32318748
[TBL] [Abstract][Full Text] [Related]
11. HGF and MET: From Brain Development to Neurological Disorders.
Desole C; Gallo S; Vitacolonna A; Montarolo F; Bertolotto A; Vivien D; Comoglio P; Crepaldi T
Front Cell Dev Biol; 2021; 9():683609. PubMed ID: 34179015
[TBL] [Abstract][Full Text] [Related]
12. SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis.
Castelli LM; Cutillo L; Souza CDS; Sanchez-Martinez A; Granata I; Lin YH; Myszczynska MA; Heath PR; Livesey MR; Ning K; Azzouz M; Shaw PJ; Guarracino MR; Whitworth AJ; Ferraiuolo L; Milo M; Hautbergue GM
Mol Neurodegener; 2021 Aug; 16(1):53. PubMed ID: 34376242
[TBL] [Abstract][Full Text] [Related]
13. Neuro faces of beneficial T cells: essential in brain, impaired in aging and neurological diseases, and activated functionally by neurotransmitters and neuropeptides.
Levite M
Neural Regen Res; 2023 Jun; 18(6):1165-1178. PubMed ID: 36453390
[TBL] [Abstract][Full Text] [Related]
14. Potential treatment of amyotrophic lateral sclerosis with gabapentin: a hypothesis.
Welty DF; Schielke GP; Rothstein JD
Ann Pharmacother; 1995 Nov; 29(11):1164-7. PubMed ID: 8573965
[TBL] [Abstract][Full Text] [Related]
15. Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.
Veenman L
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066585
[TBL] [Abstract][Full Text] [Related]
16. Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia.
Charif SE; Vassallu MF; Salvañal L; Igaz LM
Neural Regen Res; 2022 Jul; 17(7):1423-1430. PubMed ID: 34916412
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
18. Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection.
Hölscher C
CNS Drugs; 2012 Oct; 26(10):871-82. PubMed ID: 22938097
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
